Author

R. Buisson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Research Focus:chromatin & epigenetic regulation· 2 Assay:DNA methylation· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

S. Oh· 2 shared A. Abbasi· 1 shared A. Becker· 1 shared A. Langenbucher· 1 shared A. M. Dorrance· 1 shared A. N. Hata· 1 shared A. P. Urs· 1 shared A. Petri· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

S. Oh

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL-positive leukemias

D. Papaioannou, A. P. Urs, R. Buisson, A. Petri, R. Kulkarni, D. Nicolet, L. Woodward, C. Goda, K. Mrozek, G. K. Behbehani, S. Kauppinen, A.-K. Eisfeld, I. Aifantis, G. Singh, A. M. Dorrance, R. Garzon

This study identifies circPCMTD1 as a circular RNA that promotes leukemic cell proliferation by enhancing DNA damage response tolerance through a novel peptide product.

bioRxiv · Jun 27, 2024Cancer Biology

Mesoscale DNA Features Impact APOBEC3A and APOBEC3B Deaminase Activity and Shape Tumor Mutational Landscapes

A. Sanchez, P. Ortega, R. Sakhtemani, L. Manjunath, S. Oh, E. Bournique, A. Becker, K. Kim, C. Durfee, N. A. Temiz, X. Chen, R. Harris, M. Lawrence, R. Buisson

This study identifies how mesoscale DNA features influence APOBEC3A and APOBEC3B deaminase activity and their impact on tumor mutational landscapes.

bioRxiv · Aug 2, 2023Biochemistry

APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer

H. Isozaki, A. Abbasi, N. Nikpour, A. Langenbucher, W. Su, M. Stanzione, H. Frisco-Cabanos, F. M. Siddiqui, N. Phan, P. Jalili, S. Oh, D. Timonina, S. Bilton, M. Gomez-Caraballo, H. L. Archibald, , A. N. Hata

This study shows that APOBEC3A mutagenesis driven by targeted therapies promotes drug resistance in non-small cell lung cancer.

bioRxiv · Jan 20, 2021Cancer Biology